One of the most difficult things for those of us living with Migraine disease is finding ways to help others understand what it's like.
No matter how many articles we write, no matter how many letters we write for you to share with others, no matter how many heart-to-heart conversations we have, this is an ongoing problem.
The problem of the... Read more
Hello, everyone!
Wow, another week has flown by! The summer is nearly gone, some children are back in in school, and others will be returning soon.
Still, Migraines and headaches don't seem to give us much of a break, so we continue to add new material to our site for you.
So, without further ado, here's what's new since last... Read more
Phase III clinical trials for Levadex, a new Migraine abortive medication are progressing well. Levadex, from MAP Pharmaceuticals, has been referred to as MAP004 previously.
In a Phase III clinical trial at the Jefferson Headache Center in Philadelphia, participants who received Levadex experienced greater relief from pain, nausea, ... Read more
Earlier this month, I posted the article, Topamax or Topiramate for Migraine - A Difference? That article discusses problems some people are having with generic topiramate versus the brand name Topamax.
In writing that article, I talked with our very own Dr. John Claude Krusz, and I learned more about generic medications that I knew before.... Read more
The research studies that came out showing that Migraine can increase stroke risk caused strress and concern for many Migraineurs. Much of that can be attributed to the headlines used in many "news" stories as well as the failure of most of those stories to put the statistics into any kind of perspective.
For your reference, here are the... Read more